Date Filer Title Filing Type Shares Traded Price Total Held
Jun 10, 2021
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 7,528 -- 7,528
Jun 08, 2021
Chief Commercial Officer
Chief Commercial Officer Form 3 Initial Statement of Beneficial Ownership of Securities -- -- --
Jun 01, 2021
Chief Commercial Officer
Chief Commercial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 400,000 -- 400,000
May 26, 2021
Chief Financial Officer
Chief Financial Officer Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 25,000 $0.56 33,000
May 26, 2021
Chief Financial Officer
Chief Financial Officer Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 25,000 -- 200,000
May 12, 2021
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 290,000 -- 295,191
May 12, 2021
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 290,000 -- 585,191
May 12, 2021
Chief Operating Officer
Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 240,000 -- 252,086
Apr 23, 2021
Chief Medical Officer
Chief Medical Officer Form 3/A Amendment to an Initial Statement of Beneficial Ownership of Securities 10,000 -- --
Apr 23, 2021
Chief Medical Officer
Chief Medical Officer Form 3/A Amendment to an Initial Statement of Beneficial Ownership of Securities 5,000 -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.